SUMMARY The effects of long term treatment with oral amiodarone on retrograde conduction (S2H2 interval) and refractoriness of the His-Purkinje system were studied in 11 patients using His bundle electrograms and the ventricular extrastimulus method. Ten patients had ventricular tachycardia and one supraventricular tachycardia. Electrophysiological studies were carried out before and after the patients had been taking their maintenance dose for a mean duration of 84 days. After amiodarone treatment the HV interval was prolonged in seven patients and unchanged in four. At comparable S1S2 intervals, the S2H2 intervals were longer after treatment with amiodarone in all patients than before. Similarly, the longest S2H2 intervals achieved after amiodarone were longer than the control values. Amiodarone significantly increased the relative, effective, and functional refractory periods of the His-Purkinje system. Thus amiodarone exerts important effects on the His-Purkinje system. Amiodarone was originally introduced as a coronary vasodilator and antianginal agent in 1967.' Subsequent studies have shown that amiodarone has pronounced antiarrhythmic properties with beneficial effect in a wide variety of arrhythmias.24 The electrophysiological actions responsible for the antiarrhythmic effect of amiodarone are, however, poorly understood. Several clinical studies have evaluated the effects of amiodarone on the functional properties of the atrioventricular node,5 6 atrioventricular accessory pathways,7 and ventricular myocardium.8'°N evertheless, the effects of amiodarone on conduction and refractoriness of the His-Purkinje system have not been systematically studied, and there is no agreement on the effects of amiodarone on the system. Whereas Heger et a19 and others8 reported prolongation of the HV interval by amiodarone, Nademanee et al found no effect on this interval.'0 Similarly, conflicting results have been reported concerning the effect of amiodarone on the refractoriness of the HisPurkinje system.5 12 The present study was undertaken to assess the effect of long term treatment with oral amiodarone on retrograde conduction and refrac-
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Patients and methods
The study group consisted of 11 men aged between 38 and 73 (mean 59-8) years. Ten patients had recurrent ventricular tachycardia or ventricular fibrillation and one supraventricular tachycardia refractory to treatment with two or more approved antiarrhythmic drugs. Coronary artery disease was present in nine patients and no evidence of organic heart disease in two. All patients with coronary artery disease had suffered one or more myocardial infarctions.
Amiodarone was given as a loading dose of 1400 mg (four patients) or 1000 mg (seven patients) daily for an initial loading period ranging from 7 to 14 (mean (+SD) 10.2±2.2) days. Subsequently, all patients were given a maintenance dose of 400 to 800 mg daily.
Electrophysiological studies were performed in each patient before and after the patients had been taking their maintenance dose for 23 to 149 (mean (-+SD) 84±+45) days. Repeat studies were carried out to assess the efficacy of amiodarone in suppressing ventricular tachycardia. The mean total accumulated dose of amiodarone at the time of repeat study was 648
Amiodarone and His-Purkinje system conduction 63*5+32*6 g (range 18*4-106*8 g). These studies were performed using the standard pacing wire technique' 3 after informed consent had been obtained. Programmed stimulation was performed using a digital stimulator which delivered pulses of 1 ms duration at twice the diastolic threshold.
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S2H2 BLOCK (GAP) ZONES
S2H2 block is a form of retrograde gap within the His-Purkinje system in which the extrasystole S2 is blocked between the site of stimulation and that where the His bundle recording is made.'7 S2H2 block zones ranging from 10-40 ms were observed in six patients during the control study. After amiodarone, S2H2 block zones were not abolished in any patient, became wider or increased in number in three patients (Fig. 2) , and appeared in four additional patients.
RE-ENTRY WITHIN THE HIS-PURKINJE SYSTEM
In the control study re-entry within the His-Purkinje system (V3 phenomenon)17 was observed in five patients, and the zone of re-entry varied from 10 to 50 ms (Fig. 1) . After amiodarone, the V3 phenomenon was abolished in three patients and occurred over a narrower zone in two. In both of these patients reentry was initiated at a longer coupling interval and required considerably longer conduction (S2H2) delay (Fig. 1) . After amiodarone re-entry occurred in two additional patients who did not show recontrol study.
REFRACTORY PERIODS OF THE HIS-PUR SYSTEM
Amiodarone significantly prolonged th effective, and functional refractory peri His-Purkinje system (Table) . Fig. 4 show on functional refractory period of the H system before and after amiodarone for E Both the effective and the functional periods of ventricular muscle increased s after amiodarone in all patients (Table) The reasons for the absence of HV interval prolongation in some clinical studies and its presence in KINJE only some patients in most other studies including ours are not known, but possible explanations include ie relative, variability of patient selection, doses used, and duraiods of the tion of treatment. Another possible explanation for vs the effect the variable effects of amiodarone on the HV interval lis-Purkinje may be the presence or absence of disease in the Hisall patients. Purkinje system." 21 Rosenbaum et al reported refractory exacerbation of pre-existing right bundle branch significantly block during long term treatment with amiodarone. 2' In our study, nine of 11 patients had organic heart disease. Very few data are available regarding the effect of induced in long term treatment with amiodarone" on refractorifour after ness of the His-Purkinje system, and there are ventricular confficting data on the effect of intravenous tients after amiodarone.' 12 Touboul et al studied the effect of 5 riod of 14-6 mg/kg of intravenous amiodarone and reported that nine of 10 the drug prolonged the relative refractory period of one patient the His-Purkinje system in five of seven patients.' In e was with-contrast, Cabasson et al, using larger doses of ;pontaneous amiodarone, found no change in the refractory periods of the His-Purkinje system.'2 In the present study, the functional and relative refractory periods of the His-Purkinje system were prolonged in all patients, and the S2H2 block zones became wider and gs the con-occurred in more patients. On average, the functional
